Last reviewed · How we verify
Investigating How Incentives Impact Engagement With an Online Mental Health Application (Neuroflow)
NA trial testing Neuroflow app: Mental health and wellbeing resources for adults in Behavioral Economics in 107 participants. Completed in 15 May 2022.
| Lead sponsor | University of Pennsylvania |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 107 |
| Start date | 15 November 2021 |
| Primary completion | 15 April 2022 |
| Estimated completion | 15 May 2022 |
| Sites | 1 location across United States |
University of Pennsylvania
18 and older, any sex, with Behavioral Economics or Gifts, Financial. Patients with the condition only — healthy volunteers not accepted.
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
User engagement will be measured as the percentage of daily check-in activities (number completed out of the total number of activities assigned)
| Group | Value | 95% CI |
|---|---|---|
| App With Behavioral Economics + Financial Incentives | 32.8176 | ± 2.89863 |
| App With Behavioral Economics Incentives Only | 30.242 | ± 3.18953 |
Change from pre-trial to post-trial score in anxiety. Scores range from 0 to 21. Higher scores = higher symptoms of anxiety.
| Group | Value | 95% CI |
|---|---|---|
| App With Behavioral Economics + Financial Incentives | 6.58 | ± 0.781 |
| App With Behavioral Economics Incentives Only | 6.71 | ± 0.653 |
| Group | Value | 95% CI |
|---|---|---|
| App With Behavioral Economics + Financial Incentives | 4.45 | ± 0.692 |
| App With Behavioral Economics Incentives Only | 5.19 | ± 0.779 |
Change from pre-trial to post-trial score in depression. Scores range from 0-24. Higher scores = higher symptoms of depression.
| Group | Value | 95% CI |
|---|---|---|
| App With Behavioral Economics + Financial Incentives | 5.45 | ± 0.365 |
| App With Behavioral Economics Incentives Only | 6.08 | ± 0.374 |
| Group | Value | 95% CI |
|---|---|---|
| App With Behavioral Economics + Financial Incentives | 4.62 | ± 0.434 |
| App With Behavioral Economics Incentives Only | 5.3 | ± 0.427 |
Change from pre-trial to post-trial score in wellbeing. Scores range from 0-100 (raw score is multiplied by 4). Higher scores = higher wellbeing.
| Group | Value | 95% CI |
|---|---|---|
| App With Behavioral Economics + Financial Incentives | 57.95 | ± 0.361 |
| App With Behavioral Economics Incentives Only | 55.9 | ± 0.369 |
| Group | Value | 95% CI |
|---|---|---|
| App With Behavioral Economics + Financial Incentives | 58.89 | ± 0.393 |
| App With Behavioral Economics Incentives Only | 61.45 | ± 0.409 |
Change from pre-trial to post-trial score in emotion regulation difficulties. Scores range from 36-180. Higher scores = greater problems with emotion regulation.
| Group | Value | 95% CI |
|---|---|---|
| App With Behavioral Economics + Financial Incentives | 83.29 | ± 0.365 |
| App With Behavioral Economics Incentives Only | 83.22 | ± 0.369 |
| Group | Value | 95% CI |
|---|---|---|
| App With Behavioral Economics + Financial Incentives | 76.36 | ± 0.409 |
| App With Behavioral Economics Incentives Only | 74.32 | ± 0.421 |
The purpose of the study is to understand how incentives (either points alone or points that can be exchanged for gift certificates) encourage engagement with an online mental health app (Neuroflow) for University students. Overall, the hope of this study is to help the investigators understand how best to support mental health and wellness in university students.
1 peer-reviewed publication reference this trial (live from Europe PMC):
Verify or expand the search:
Currently open trials in the same condition.
Trials by the same sponsor.
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05121675.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing